September 14, 2018
March 28, 2018Full List »
Dr. Kerlavage became the Director of the National Cancer Institute’s Center for Biomedical Informatics and Information Technology (CBIIT) in 2019. He served as Acting Director since 2017, and as the Chief of the Cancer Informatics Branch starting in 2011. He has overseen programs including omics data management and analysis, cloud computing, imaging informatics, clinical trials infrastructure, precision medicine decision support, and semantics and interoperability. He has spearheaded NCI’s efforts in open data, open software, and open science though establishment of the Cancer Cloud Resources and the Cancer Research Data Commons.
Prior to joining the NCI, Dr. Kerlavage spent over 25 years in the public and private sector as a leader in bioinformatics and genomics. After his post-doctoral work at University of Pennsylvania, he spent seven years at the National Institute of Neurological Disorders and Stroke (NINDS) working on the structure of neurotransmitter receptors and identifying genes expressed in the brain. He left the NIH to become a founding member of The Institute for Genomic Research (TIGR), focusing on informatics support for whole genome sequencing and analysis, and subsequently, Celera Genomics, where he managed their online information business, providing access to the first version of the human genome. He spent several years at Applied Biosystems and Life Technologies, where he supported global customers with intelligent monitoring systems for scientific instrumentation, LIMS systems, and computational infrastructure support for next-generation sequencing technologies. Dr. Kerlavage received an MS and PhD from UC San Diego, and his undergraduate degree from Penn State, all in Chemistry.